Life Science & Medical Technology

RIKEN’s research related to COVID-19
RIKEN hosted a special online seminar on its research related to COVID-19 on July 15, 2020. The event was organized for an international audience in order to strengthen collaboration with research institutes, universities and companies all around the globe.
Daikin to develop medical face mask with national institute

Japanese air-conditioner maker Daikin Industries will develop a high-performance reusable medical face mask in cooperation with the National Cerebral and Cardiovascular Center and CrossEffect, a Kyoto-based three-dimensional engineering company.

Shionogi to ready COVID-19 vaccines for 30m people

Japanese drugmaker Shionogi plans to increase production capacity for its coronavirus vaccine candidate, aiming to turn out enough vaccines for 30 million people per year by the end of 2021, as competition intensifies to develop COVID-19 treatments, Nikkei has learned.

Possible vaccine protein for COVID-19 made in silkworms
Kyushu University has used silkworms to develop a protein that could become a candidate vaccine for COVID-19, officials said. The university, known as a world-class institution for silkworm studies, hopes to start clinical research for the vaccine as early as fiscal 2021. The vaccine could be mass-produced at an “insect plant,” keeping down the cost per inoculation to only several thousand yen (tens of dollars)